
Buvalor 10mg Transdermal Patch
Marketer
Modi Mundi Pharma Pvt Ltd
Salt Composition
Buprenorphine (10mg)
Overview Buvalor 10mg Transdermal Patch
Opioid addiction and moderate-to-severe pain are managed with the Buvalor 10mg transdermal patch. This patch mitigates opioid withdrawal symptoms. Administering Buvalor 10mg requires precise adherence to your physician's instructions for optimal efficacy. Dosage and treatment length vary based on individual needs and response. Consistent use is crucial; cessation should only occur under medical supervision. Commonly reported side effects include nausea, constipation, drowsiness, dizziness, and headache. These effects may be more pronounced initially or following dosage increases, generally subsiding with continued use. Persistent or severe side effects warrant patch removal and immediate medical attention. Pre-existing conditions and concurrent medications must be disclosed to your doctor prior to commencing treatment, ensuring medication safety and compatibility. Pregnant or breastfeeding individuals should seek medical counsel before using Buvalor.
Uses of Buvalor 10mg Transdermal Patch
Morphine addiction; Management of significant to intense pain
Major Benefits of Buvalor 10mg Transdermal Patch:
Administer this medication according to your physician's prescribed dosage and schedule. Always verify the product information before application. Ensure the application site is clean and completely dry. Peel away the patch's protective covering. Avoid contact with the adhesive surface. Apply the patch firmly to the skin, adhesive side down, ensuring even contact.
Common Side effects of Buvalor 10mg Transdermal Patch:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buvalor 10mg Transdermal Patch:
Apply this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Always verify the product details on the packaging prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective backing. Avoid contact with the adhesive surface. Apply the patch firmly to the skin with the adhesive side facing downwards, ensuring even contact.
How Buvalor 10mg Transdermal Patch works:
The transdermal Buvalor 10mg patch, a partial opioid agonist, mitigates opioid withdrawal by mimicking the effects of opioid medications. Its analgesic action stems from interaction with specific brain receptors, modifying pain perception and response.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
Using the Buvalor 10mg transdermal patch during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Employing the Buvalor 10mg transdermal patch while breastfeeding is likely inadvisable. Scant human evidence indicates potential drug transfer into breast milk, posing a risk to the infant.
DrivingNone
No known drug interactions.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Buvalor 10mg Transdermal Patches requires careful consideration. A modified dosage of Buvalor 10mg Transdermal Patches might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe liver disease should use the Buvalor 10mg Transdermal Patch cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with significant hepatic dysfunction, an alternative pain reliever offering greater dosing flexibility may be preferable.
What if you forget to take Buvalor 10mg Transdermal Patch :
NA
Facts to Know About Buvalor 10mg Transdermal Patch
| Label | Value |
|---|---|
| Chemical Category | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience of the Central Nervous System |
